🔗 Share this article

The prestigious award in medical science was granted for transformative discoveries that clarify how the body's defense network attacks harmful pathogens while sparing the body's own cells.

A trio of renowned researchers—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their work identified specialized "sentinels" within the defense system that eliminate rogue defense cells capable of harming the body.

These discoveries are now paving the way for new treatments for autoimmune diseases and malignancies.

The winners will share a monetary award worth 11m SEK.

Crucial Findings

"Their research has been essential for comprehending how the body's defenses operates and why we do not all suffer from severe self-attack conditions," stated the head of the award panel.

This trio's research explain a core question: In what way does the defense system defend us from countless invaders while keeping our own tissues intact?

The immune system employs white blood cells that search for indicators of disease, even pathogens and bacteria it has never encountered.

Such cells utilize detectors—called receptors—that are produced randomly in countless combinations.

That provides the immune system the ability to combat a broad range of invaders, but the randomness of the mechanism inevitably produces white blood cells that can target the body.

Security Guards of the Immune System

Researchers earlier understood that a portion of these harmful defense cells were destroyed in the thymus—the site where immune cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the body's "peacekeepers"—which patrol the body to disarm other immune cells that attack the healthy cells.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "The discoveries have laid the foundation for a novel area of investigation and accelerated the creation of innovative therapies, for example for tumors and immune disorders."

Regarding malignancies, regulatory T-cells prevent the system from attacking the tumor, so research are focused on lowering their numbers.

For autoimmune diseases, trials are exploring increasing T-reg cells so the body is no longer being harmed. A similar approach could also be effective in minimizing the risks of transplanted organ failure.

Pioneering Experiments

Prof Sakaguchi, of Osaka University, performed experiments on mice that had their immune gland extracted, causing autoimmune disease.

He demonstrated that introducing immune cells from healthy animals could prevent the illness—suggesting there was a mechanism for preventing defenders from harming the host.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited autoimmune disease in rodents and humans that led to the discovery of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking work has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a prominent biological science expert.

"This work is a remarkable illustration of how basic physiological study can have far-reaching consequences for human health."